Chuan Fu Biotech Announces Board Approval of Consolidated Financial Statements for Q2 115

Release Date: August 8, 115 Statement Date: August 7, 115 Statement Time: 16:56:10 Company Code: 6885 Company Name: Chuan Fu Biotech Subject: Announcement of the Board Resolution Approving the Consolidated Financial Statements for the Second Quarter of Year 115 Applicable Clause: Item 31 Event Date: August 7, 115 Details: 1. Date reported to or resolved by the board: August 7, 115 2. Audit Committee approval date: August 7, 115 3. Reporting period for financial report or self-calculated annual financial information (start~end): January 1, 115 ~ June 30, 115 4. Cumulative operating revenue from January 1 to current period (in thousand NTD): 6,790 5. Cumulative operating profit (loss) from January 1 to current period (in thousand NTD): -1,166 6. Cumulative operating income (loss) from January 1 to current period (in thousand NTD): -169,354 7. Cumulative pre-tax net profit (loss) from January 1 to current period (in thousand NTD): -203,887 8. Cumulative net profit (loss) for the period from January 1 to current period (in thousand NTD): -203,920 9. Cumulative net profit (loss) attributable to owners of parent from January 1 to current period (in thousand NTD): -182,714 10. Cumulative basic earnings per share (EPS) from January 1 to current period (in NTD): -1.39 11. Total assets at end of period (in thousand NTD): 1,663,150 12. Total liabilities at end of period (in thousand NTD): 42,912 13. Equity attributable to owners of parent at end of period (in thousand NTD): 1,542,820 14. Other matters to be disclosed: None